Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications (Q38601445)

From Wikidata

Jump to navigation Jump to search

scientific article published on 19 September 2015

Language	Label	Description	Also known as
English	Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications	scientific article published on 19 September 2015

Statements

scholarly article

1 reference

Europe PubMed Central

4 September 2017

Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications (English)

1 reference

Europe PubMed Central

4 September 2017

Alzheimer's disease

0 references

disease biology

1 reference

based on heuristic

inferred from title

author name string

Niraj Kumar Jha

1

1 reference

Europe PubMed Central

4 September 2017

Saurabh Kumar Jha

2

1 reference

Europe PubMed Central

4 September 2017

Dhiraj Kumar

3

1 reference

Europe PubMed Central

4 September 2017

Noopur Kejriwal

4

1 reference

Europe PubMed Central

4 September 2017

Renu Sharma

5

1 reference

Europe PubMed Central

4 September 2017

Rashmi K Ambasta

6

1 reference

Europe PubMed Central

4 September 2017

Pravir Kumar

7

1 reference

Europe PubMed Central

4 September 2017

publication date

19 September 2015

1 reference

Europe PubMed Central

4 September 2017

Journal of Alzheimer's Disease

1 reference

Europe PubMed Central

4 September 2017

48

1 reference

Europe PubMed Central

4 September 2017

4

1 reference

Europe PubMed Central

4 September 2017

891-917

1 reference

Europe PubMed Central

4 September 2017

Molecular mechanisms of neurodegeneration in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Role of tau protein in both physiological and pathological conditions.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Alzheimer's disease is type 3 diabetes-evidence reviewed

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Effects of insulin on cultured rat brain cells: stimulation of ornithine decarboxylase activity

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Potential roles of insulin and IGF-1 in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Effect of insulin on GABAergic development in the embryonic chick retina.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

High glucose-induced oxidative stress and mitochondrial dysfunction in neurons.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: an update

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Common pathological processes in Alzheimer disease and type 2 diabetes: a review

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Insulin resistance, affective disorders, and Alzheimer's disease: review and hypothesis

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Insulin and cognitive function in an elderly population. The Rotterdam Study.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Hyperinsulinemia and risk of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Blockade of the insulin-like growth factor I receptor in the choroid plexus originates Alzheimer's-like neuropathology in rodents: new cues into the human disease?

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Effects of Alzheimer's amyloid-beta and tau protein on mitochondrial function -- role of glucose metabolism and insulin signalling

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Insulin and the insulin receptor in experimental models of learning and memory.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Insulin signaling in the central nervous system: learning to survive

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Insulin is a two-edged knife on the brain

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

A neuroprotective brain-penetrating endopeptidase fusion protein ameliorates Alzheimer disease pathology and restores neurogenesis

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Purification of endopeptidase-24.11 ('enkephalinase') from pig brain by immunoadsorbent chromatography

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Molecular cloning and amino acid sequence of human enkephalinase (neutral endopeptidase).

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Organization of the gene encoding common acute lymphoblastic leukemia antigen (neutral endopeptidase 24.11): multiple miniexons and separate 5' untranslated regions

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Engineering Neprilysin Activity and Specificity to Create a Novel Therapeutic for Alzheimer’s Disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Structural analysis of neprilysin with various specific and potent inhibitors

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

The neprilysin (NEP) family of zinc metalloendopeptidases: genomics and function

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Amyloid beta-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Presynaptic localization of neprilysin contributes to efficient clearance of amyloid-beta peptide in mouse brain.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Membrane Localization of Endopeptidase‐24.11 and Peptidyl Dipeptidase A (Angiotensin Converting Enzyme) in the Pig Brain: A Study Using Subcellular Fractionation and Electron Microscopic Immunocytochemistry

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Effects of hypoxia and oxidative stress on expression of neprilysin in human neuroblastoma cells and rat cortical neurones and astrocytes

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

An immunohistochemical study of endopeptidase-24.11 ("enkephalinase") in the pig nervous system.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Neuropeptide Y and its receptors as potential therapeutic drug targets

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Alterations within the endogenous opioid system in mice with targeted deletion of the neutral endopeptidase ('enkephalinase') gene

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Biochemical identification of the neutral endopeptidase family member responsible for the catabolism of amyloid beta peptide in the brain.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Metabolism of amyloid β peptide and pathogenesis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Amyloid-degrading enzymes as therapeutic targets in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Metabolism of amyloid-beta peptide and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Meta-analysis of the association between two neprilysin gene polymorphisms and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Determination of hypoxic effect on neprilysin activity in human neuroblastoma SH-SY5Y cells using a novel HPLC method

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Oxidized neprilysin in aging and Alzheimer's disease brains

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Gapped BLAST and PSI-BLAST: a new generation of protein database search programs

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Asp650 is crucial for catalytic activity of neutral endopeptidase 24-11

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Structural studies of a bifunctional inhibitor of neprilysin and DPP-IV

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

ScanProsite: detection of PROSITE signature matches and ProRule-associated functional and structural residues in proteins

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Substitution of potential metal-coordinating amino acid residues in the zinc-binding site of endopeptidase-24.11.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Post-translational myristoylation: Fat matters in cellular life and death

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Effects of glycosylation on the stability of protein pharmaceuticals

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Analysis Tool Web Services from the EMBL-EBI.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

SCOP: a structural classification of proteins database

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Inhibitors of neprilysin: design, pharmacological and clinical applications.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Dali server: conservation mapping in 3D

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Insulin-degrading enzyme rapidly removes the beta-amyloid precursor protein intracellular domain (AICD)

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Molecular Bases for the Recognition of Short Peptide Substrates and Cysteine-Directed Modifications of Human Insulin-Degrading Enzyme †

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Insulin degradation: mechanisms, products, and significance

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Endoplasmic reticulum-localized amyloid beta-peptide is degraded in the cytosol by two distinct degradation pathways

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Alternative translation initiation generates a novel isoform of insulin-degrading enzyme targeted to mitochondria

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Insulin-degrading enzyme exists inside of rat liver peroxisomes and degrades oxidized proteins

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Genetic aspects of Alzheimer disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Amylin and its analogs: a friend or foe for the treatment of Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Insulin clearance in obesity

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Insulin-degrading enzyme: embarking on amyloid destruction.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Beta-endorphin 1-31 biotransformation and cAMP modulation in inflammation

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Identification of gamma-endorphin-generating enzyme as insulin-degrading enzyme

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Structural changes in intermediate filament networks alter the activity of insulin-degrading enzyme

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Reduced amyloid-β degradation in early Alzheimer's disease but not in the APPswePS1dE9 and 3xTg-AD mouse models

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Transformation of amyloid β(1-40) oligomers into fibrils is characterized by a major change in secondary structure

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

The effect of amyloid associated proteins on the expression of genes involved in amyloid-β clearance by adult human astrocytes.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Structure, function, and regulation of insulin-degrading enzyme

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Substrate activation of insulin-degrading enzyme (insulysin). A potential target for drug development.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

The insulin/Akt signaling pathway is targeted by intracellular beta-amyloid

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Insulin stimulates postsynaptic density-95 protein translation via the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Signaling by insulin-like growth factor 1 in brain

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Role of insulin and insulin receptor in learning and memory

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Insulin-like growth factor-I enhances transforming growth factor-beta-induced extracellular matrix protein production through the P38/activating transcription factor-2 signaling pathway in keloid fibroblasts

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

The role of insulin, insulin growth factor, and insulin-degrading enzyme in brain aging and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Molecular Basis of Catalytic Chamber-assisted Unfolding and Cleavage of Human Insulin by Human Insulin-degrading Enzyme

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Trafficking and proteolytic processing of APP

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Alzheimer's disease and the amyloid-beta peptide

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

The Aβ-clearance protein transthyretin, like neprilysin, is epigenetically regulated by the amyloid precursor protein intracellular domain.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Transcriptional regulation of insulin-degrading enzyme modulates mitochondrial amyloid β (Aβ) peptide catabolism and functionality.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

ApoE promotes the proteolytic degradation of Abeta

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

New therapeutic approaches for Alzheimer's disease and cerebral amyloid angiopathy

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Alzheimer's disease: strategies for disease modification

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Regulation of steady-state beta-amyloid levels in the brain by neprilysin and endothelin-converting enzyme but not angiotensin-converting enzyme.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Additive effects of PS1 and APP mutations on secretion of the 42-residue amyloid beta-protein.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Peripheral delivery of a CNS targeted, metalo-protease reduces aβ toxicity in a mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Neprilysin protects human neuronal progenitor cells against impaired development caused by amyloid-beta peptide.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Peripherally expressed neprilysin reduces brain amyloid burden: a novel approach for treating Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Circulating neprilysin clears brain amyloid

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Clearance of extracellular and cell-associated amyloid beta peptide through viral expression of neprilysin in primary neurons.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Mechanisms of Amyloid-β Peptide Clearance: Potential Therapeutic Targets for Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Recombinant soluble neprilysin reduces amyloid-beta accumulation and improves memory impairment in Alzheimer's disease mice

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Herpes simplex virus RNAi and neprilysin gene transfer vectors reduce accumulation of Alzheimer's disease-related amyloid-beta peptide in vivo

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

AAV9: a potential blood-brain barrier buster

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Trafficking CD11b-positive blood cells deliver therapeutic genes to the brain of amyloid-depositing transgenic mice

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Aβ-degrading enzymes: potential for treatment of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Nonsteroidal selective androgen receptor modulators and selective estrogen receptor β agonists moderate cognitive deficits and amyloid-β levels in a mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Nitric oxide decreases the enzymatic activity of insulin degrading enzyme in APP/PS1 mice.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Amyloid β inhibits retinoic acid synthesis exacerbating Alzheimer disease pathology which can be attenuated by an retinoic acid receptor α agonist

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Interleukin-34 selectively enhances the neuroprotective effects of microglia to attenuate oligomeric amyloid-β neurotoxicity

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Loss of interleukin receptor-associated kinase 4 signaling suppresses amyloid pathology and alters microglial phenotype in a mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Mitochondria-targeted catalase reduces abnormal APP processing, amyloid β production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Long-term immunomodulatory effect of amniotic stem cells in an Alzheimer's disease model

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Degradation of amyloid beta by human induced pluripotent stem cell-derived macrophages expressing Neprilysin-2.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Neural stem cells genetically-modified to express neprilysin reduce pathology in Alzheimer transgenic models

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

PF-04494700, an oral inhibitor of receptor for advanced glycation end products (RAGE), in Alzheimer disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Overexpression of neprilysin reduces alzheimer amyloid-beta42 (Abeta42)-induced neuron loss and intraneuronal Abeta42 deposits but causes a reduction in cAMP-responsive element-binding protein-mediated transcription, age-dependent axon pathology, an

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Structure of substrate-free human insulin-degrading enzyme (IDE) and biophysical analysis of ATP-induced conformational switch of IDE

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Effect of sodium valproate administration on brain neprilysin expression and memory in rats

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Valproic acid reduces neuritic plaque formation and improves learning deficits in APP(Swe) /PS1(A246E) transgenic mice via preventing the prenatal hypoxia-induced down-regulation of neprilysin.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Somatostatin: a novel substrate and a modulator of insulin-degrading enzyme activity

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Somatostatin modulates insulin-degrading-enzyme metabolism: implications for the regulation of microglia activity in AD

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, substrate-dependent modulators of insulin-degrading enzyme in amyloid-β hydrolysis

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Cysteine 904 is required for maximal insulin degrading enzyme activity and polyanion activation

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

BRI2 protein regulates β-amyloid degradation by increasing levels of secreted insulin-degrading enzyme (IDE).

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

[A drug targeting intracellular amyloid-β and oxidative stress: apomorphine].

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Leptin reduces the accumulation of Abeta and phosphorylated tau induced by 27-hydroxycholesterol in rabbit organotypic slices

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Degradation of soluble amyloid beta-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Estrogen stimulates degradation of beta-amyloid peptide by up-regulating neprilysin

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

A humanin derivative reduces amyloid beta accumulation and ameliorates memory deficit in triple transgenic mice

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

An Aβ42 uptake and degradation via Rg3 requires an activation of caveolin, clathrin and Aβ-degrading enzymes in microglia.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Ginsenoside Rg1 decreases Aβ(1-42) level by upregulating PPARγ and IDE expression in the hippocampus of a rat model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

A PPARdelta agonist reduces amyloid burden and brain inflammation in a transgenic mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Enhancement of neutral endopeptidase activity in SK-N-SH cells by green tea extract

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Mechanisms and effects of curcumin on spatial learning and memory improvement in APPswe/PS1dE9 mice

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Possible role of resveratrol targeting estradiol and neprilysin pathways in lipopolysaccharide model of Alzheimer disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Norepinephrine promotes microglia to uptake and degrade amyloid beta peptide through upregulation of mouse formyl peptide receptor 2 and induction of insulin-degrading enzyme.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Protective actions of sex steroid hormones in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Androgens activate mitogen-activated protein kinase signaling: role in neuroprotection

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Estrogen regulates neprilysin activity in rat brain

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Androgens regulate neprilysin expression: role in reducing beta-amyloid levels.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Nobiletin, a flavone from Citrus depressa, induces gene expression and increases the protein level and activity of neprilysin in SK-N-SH cells

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Sevoflurane alters the expression of receptors and enzymes involved in Aβ clearance in rats

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Impaired amyloid β-degrading enzymes in brain of streptozotocin-induced diabetic rats.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Thiorphan-induced neprilysin inhibition raises amyloid beta levels in rabbit cortex and cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

NEP-like endopeptidases and Alzheimer's disease [corrected].

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Neprilysin activity and expression are controlled by nicastrin

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Ketamine reduces amyloid β-protein degradation by suppressing neprilysin expression in primary cultured astrocytes

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Spinorphin, an endogenous inhibitor of enkephalin-degrading enzymes, potentiates leu-enkephalin-induced anti-allodynic and antinociceptive effects in mice

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Sialorphin, a natural inhibitor of rat membrane-bound neutral endopeptidase that displays analgesic activity

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Human Opiorphin, a natural antinociceptive modulator of opioid-dependent pathways

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Copper downregulates neprilysin activity through modulation of neprilysin degradation.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

In vitro Pb exposure disturbs the balance between Aβ production and elimination: the role of AβPP and neprilysin

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Leptin inhibits amyloid β-protein degradation through decrease of neprilysin expression in primary cultured astrocytes.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Structure–Activity Relationship Study of Opiorphin, a Human Dual Ectopeptidase Inhibitor with Antinociceptive Properties

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150379

21 January 2018

Identifiers

10.3233/JAD-150379

1 reference

Europe PubMed Central

4 September 2017

1 reference

Europe PubMed Central

4 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38601445&oldid=1769730663"